Literature DB >> 945062

A chemical basis for the antitumor activity of chloroethylnitrosoureas.

M Colvin, R B Brundrett, W Cowens, I Jardine, D B Ludlum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 945062     DOI： 10.1016/0006-2952(76)90246-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

1.  Comparative interactions of streptozotocin and chlorozotocin with DNA of an insulin-secreting cell line (RINr).

Authors:  B T Mossman; C M Ireland; M Filipak; S LeDoux; G L Wilson
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

2.  DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas.

Authors:  L C Erickson; M O Bradley; J M Ducore; R A Ewig; K W Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

3.  Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study.

Authors:  Daniel A Hamstra; Bradford A Moffat; Daniel E Hall; John M Young; Timothy J Desmond; Julie Carter; Dennis Pietronigro; Kirk A Frey; Alnawaz Rehemtulla; Brian D Ross
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

4.  Increased degradation rate of nitrososureas in media containing carbonate.

Authors:  Janeric Seidegård; Lena Grönquist; Helen Tuvesson; Per-Olov Gunnarsson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

5.  Increased cytotoxicity of 1-(2-chloroethyl)-1-nitroso-3(4-methyl)-cyclohexylurea by pretreatment with O6-methylguanine in resistant but not in sensitive human melanoma cells.

Authors:  W Dempke; P Nehls; U Wandl; D Soll; C G Schmidt; R Osieka
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

6.  Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.

Authors:  V A Levin; P A Kabra; M A Freeman-Dove
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 7.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

8.  Cyclophosphamide, cisplatin, and carmustine: pharmacokinetics of carmustine following multiple alkylating-agent interactions.

Authors:  R B Jones; S Matthes; D Kemme; C Dufton; S Kernan
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 9.  Urea-based anticancer agents. Exploring 100-years of research with an eye to the future.

Authors:  Roberta Listro; Giacomo Rossino; Federica Piaggi; Falilat Folasade Sonekan; Daniela Rossi; Pasquale Linciano; Simona Collina
Journal:  Front Chem       Date:  2022-09-15       Impact factor: 5.545

10.  Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites and MGMT Expression in Canine Cells.

Authors:  Thushara Chakkath; Sidonie Lavergne; Timothy M Fan; David Bunick; Levent Dirikolu
Journal:  Vet Sci       Date:  2015-04-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.